Viewing Study NCT01405950


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-02-12 @ 2:58 AM
Study NCT ID: NCT01405950
Status: TERMINATED
Last Update Posted: 2013-06-17
First Post: 2011-07-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
Sponsor: Acorda Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AT10-ZC-08
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View